Progynova Interactions
There are 393 drugs known to interact with Progynova (estradiol), along with 17 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 35 are major, 337 are moderate, and 21 are minor.
- View all 393 medications that may interact with Progynova
- View Progynova alcohol/food interactions (4)
- View Progynova disease interactions (17)
Most frequently checked interactions
View interaction reports for Progynova (estradiol) and the medicines listed below.
- amitriptyline
- aspirin
- cetirizine
- Clexane (enoxaparin)
- dextroamphetamine
- Endep (amitriptyline)
- esomeprazole
- finasteride
- fluoxetine
- folic acid
- furosemide
- ibuprofen
- Nexium (esomeprazole)
- omeprazole
- oxycodone
- pantoprazole
- Paracetamol (acetaminophen)
- Plaquenil (hydroxychloroquine)
- prednisolone
- prednisone
- progesterone
- Prometrium (progesterone)
- rosuvastatin
- sertraline
- spironolactone
- tramadol
- venlafaxine
- Vitamin B Complex 100 (multivitamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Progynova alcohol/food interactions
There are 4 alcohol/food interactions with Progynova (estradiol).
Progynova disease interactions
There are 17 disease interactions with Progynova (estradiol) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Progynova (estradiol)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.